retatrutide clinical trials phase 3 results New data just dropped 👀 Eli Lilly's trial reported average WLWT | Pharmaceutical giant Eli

In its first registrational Phase 3 obesity trial (TRIUMPH-1), average weight loss reached 28.3% at 80 weeks and up to 30.3% at 104 weeks in a select extension cohort

It should not be used if you are taking opioid medications, have a history of seizures, eating disorders, or are stopping alcohol or benzodiazepines abruptly

Other drugs may interact with phentermine and topiramate, including prescription and over-the-counter medicines, vitamins, and herbal products

At the level of the vascular smooth muscle cells, they protect against pathogenic, proliferative remodeling of the vascular smooth muscle cells, thus delaying plaque formation and stabilizing existing lesions

doi: 10.2337/dc19-0883